Quest Diagnostics Incorporated (NYSE:DGX) entered into a definitive agreement to acquire Select Laboratory Assets of OhioHealth on July 10, 2024. After the acquisition's close, most outreach testing performed by OhioHealth will transition to the Quest Diagnostics full-service laboratory in Pittsburgh, Pennsylvania. OhioHealth will continue to wholly own and operate its hospital labs, providing high quality laboratory services for inpatient and hospital-based outpatient care as well as anatomic pathology and oncology.

The parties expect to complete the transaction in the third quarter of 2024, and assuming customary regulatory reviews.